483 Response Epic Pharma Jan 2006

Paul Mouris FDA, Robert Steyert FDA$119.00 - Available Now

FDA investigators audited the Epic Pharma - Laurelton, NY, United States facility and issued inspectional observation (via FDA 483) on 25 Jan 2006.

Product details

  • Category:
  • Inspection end: 25 Jan 2006
  • Location: Laurelton, United States
  • FEI: 2431929
Add To Cart